AstraZeneca signs AI research deal with China’s CSPC for chronic diseases

June 13, 2025

, By The Economic Times

Share via:

rel=”dofollow” href=”https://economictimes.indiatimes.com/astrazeneca-pharma-india-ltd/stocks/companyid-13987.cms” data-ga-onclick=”Inarticle articleshow link click#Tech#href” target=”_blank”>AstraZeneca has signed an AI-led research agreement with China’s ref=”dofollow” data-ga-onclick=”Inarticle articleshow link click#Tech#href” href=”https://economictimes.indiatimes.com/topic/cspc-pharmaceutical-group” target=”_blank”>CSPC Pharmaceutical Group worth up to $5.3 billion, which would help the Anglo-Swedish drugmaker develop therapies for chronic conditions, it said on Friday.

The deal marks the latest effort by AstraZeneca to revive its business in China, its second-biggest market, where it has faced several challenges including the arrest of its China president last year and potential fines related to imports.

Under Friday’s agreement, the two companies will collaborate to discover and develop…

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Previous News

Google rejects app store age verification for online content

Next News

Affordable Mobility in Dubai Starts with OneClickDrive’s Used Car Listings

The Economic Times

Popular

More Like this

AstraZeneca signs AI research deal with China’s CSPC for chronic diseases

June 13, 2025

, Published By The Economic Times

rel=”dofollow” href=”https://economictimes.indiatimes.com/astrazeneca-pharma-india-ltd/stocks/companyid-13987.cms” data-ga-onclick=”Inarticle articleshow link click#Tech#href” target=”_blank”>AstraZeneca has signed an AI-led research agreement with China’s ref=”dofollow” data-ga-onclick=”Inarticle articleshow link click#Tech#href” href=”https://economictimes.indiatimes.com/topic/cspc-pharmaceutical-group” target=”_blank”>CSPC Pharmaceutical Group worth up to $5.3 billion, which would help the Anglo-Swedish drugmaker develop therapies for chronic conditions, it said on Friday.

The deal marks the latest effort by AstraZeneca to revive its business in China, its second-biggest market, where it has faced several challenges including the arrest of its China president last year and potential fines related to imports.

Under Friday’s agreement, the two companies will collaborate to discover and develop…

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

Previous News

Google rejects app store age verification for online content

Next News

Affordable Mobility in Dubai Starts with OneClickDrive’s Used Car Listings

The Economic Times

More like this

Popular

Block title